FI109204B - Immuunimäärityksiä ja monoklonaalisia vasta-aineita protrombiiniaktivaatiopeptideille ja niiden hajoamistuotteille - Google Patents

Immuunimäärityksiä ja monoklonaalisia vasta-aineita protrombiiniaktivaatiopeptideille ja niiden hajoamistuotteille Download PDF

Info

Publication number
FI109204B
FI109204B FI922017A FI922017A FI109204B FI 109204 B FI109204 B FI 109204B FI 922017 A FI922017 A FI 922017A FI 922017 A FI922017 A FI 922017A FI 109204 B FI109204 B FI 109204B
Authority
FI
Finland
Prior art keywords
prothrombin
antibody
antibodies
monoclonal antibody
labeled
Prior art date
Application number
FI922017A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI922017A0 (fi
FI922017A (fi
Inventor
Bryan Timothy Butman
Jerald Paul Steiner
Bryant Mckoy Moore
Frederick Anthony Dombrose
Marcie Jones Hursting
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23714193&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI109204(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI922017A0 publication Critical patent/FI922017A0/fi
Publication of FI922017A publication Critical patent/FI922017A/fi
Application granted granted Critical
Publication of FI109204B publication Critical patent/FI109204B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Exhaust Gas After Treatment (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Transceivers (AREA)
FI922017A 1989-11-06 1992-05-05 Immuunimäärityksiä ja monoklonaalisia vasta-aineita protrombiiniaktivaatiopeptideille ja niiden hajoamistuotteille FI109204B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43196489A 1989-11-06 1989-11-06
US43196489 1989-11-06
US9006501 1990-11-02
PCT/US1990/006501 WO1991006861A1 (fr) 1989-11-06 1990-11-02 Immunoanalyses de detection d'anticorps monoclonaux contre les peptides d'activation de prothrombine et leurs produits de degradation

Publications (3)

Publication Number Publication Date
FI922017A0 FI922017A0 (fi) 1992-05-05
FI922017A FI922017A (fi) 1992-05-05
FI109204B true FI109204B (fi) 2002-06-14

Family

ID=23714193

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922017A FI109204B (fi) 1989-11-06 1992-05-05 Immuunimäärityksiä ja monoklonaalisia vasta-aineita protrombiiniaktivaatiopeptideille ja niiden hajoamistuotteille

Country Status (15)

Country Link
US (1) US5830681A (fr)
EP (1) EP0594576B1 (fr)
JP (1) JP2918688B2 (fr)
KR (1) KR100202773B1 (fr)
AT (1) ATE182366T1 (fr)
AU (1) AU655918B2 (fr)
CA (1) CA2071211C (fr)
DE (1) DE69033220T2 (fr)
DK (1) DK0594576T3 (fr)
ES (1) ES2136598T3 (fr)
FI (1) FI109204B (fr)
GR (1) GR3031607T3 (fr)
IE (1) IE903930A1 (fr)
WO (1) WO1991006861A1 (fr)
ZA (1) ZA908778B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3727610A1 (de) 1987-08-19 1989-03-02 Behringwerke Ag Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung
US5942443A (en) * 1996-06-28 1999-08-24 Caliper Technologies Corporation High throughput screening assay systems in microscale fluidic devices
EP0907412B1 (fr) 1996-06-28 2008-08-27 Caliper Life Sciences, Inc. Systeme de dosage de criblage a fort rendement dans des dispositifs microscopiques de transfert de fluides
AUPP460398A0 (en) * 1998-07-10 1998-08-06 Life Therapeutics Limited Lupus anticoagulant
JP2003524187A (ja) * 2000-02-23 2003-08-12 ベッスト−テスト アンパーツゼルスカブ 体液、例えば尿におけるマーカーと血液凝固活性とを相互関連づけるための方法
US20020098516A1 (en) * 2000-10-03 2002-07-25 Boystown National Research Hospital Immunodiagnostic determination of usher syndrome type IIA
DE10354403A1 (de) 2003-11-20 2005-06-23 Dade Behring Marburg Gmbh Gegen das Prothrombin-Fragment F 1+2 gerichtete Antikörper, ihre Herstellung und Verwendung
DE102004042124B4 (de) * 2004-08-30 2006-07-06 Dade Behring Marburg Gmbh Homogenes Verfahren zur Bestimmung eines Analyten in Gegenwart eines Überschusses von kreuzreagierenden Substanzen
KR100967614B1 (ko) * 2008-03-14 2010-07-05 주식회사 바이오인프라 Ｄｅｓ－Ｒ 프로트롬빈 활성 펩티드 단편 Ｆ２의 혈청 내농도 측정을 통한 암의 진단 및 스크리닝 방법
DE102008049601A1 (de) 2008-09-30 2010-04-01 Siemens Healthcare Diagnostics Products Gmbh Antikörper zur Bestimmung des Prothrombin-Fragments F2/F1+2 in einem homogenen Immunoassay
GB2483402B (en) 2009-06-04 2014-04-09 Lockheed Corp Multiple-sample microfluidic chip for DNA analysis
CA2814720C (fr) 2010-10-15 2016-12-13 Lockheed Martin Corporation Conception optique microfluidique
US9322054B2 (en) 2012-02-22 2016-04-26 Lockheed Martin Corporation Microfluidic cartridge
EP4239338A1 (fr) 2022-03-03 2023-09-06 Siemens Healthcare Diagnostics Products GmbH Essai général destiné à la détermination de l'état du système de coagulation sanguine
WO2023208941A1 (fr) 2022-04-26 2023-11-02 Essilor International Article optique photochromique ayant un revêtement miroir
EP4325224A1 (fr) 2022-08-18 2024-02-21 Siemens Healthcare Diagnostics Products GmbH Essai d'activation plaquettaire destiné au diagnostic d'une thrombocytopénie induite à l'héparine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3727610A1 (de) * 1987-08-19 1989-03-02 Behringwerke Ag Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung

Also Published As

Publication number Publication date
ES2136598T3 (es) 1999-12-01
KR100202773B1 (ko) 1999-06-15
US5830681A (en) 1998-11-03
WO1991006861A1 (fr) 1991-05-16
GR3031607T3 (en) 2000-01-31
EP0594576A4 (fr) 1993-03-15
DK0594576T3 (da) 2000-02-07
ZA908778B (en) 1991-10-30
FI922017A0 (fi) 1992-05-05
CA2071211C (fr) 2003-02-18
EP0594576B1 (fr) 1999-07-21
EP0594576A1 (fr) 1994-05-04
CA2071211A1 (fr) 1991-05-07
JP2918688B2 (ja) 1999-07-12
ATE182366T1 (de) 1999-08-15
FI922017A (fi) 1992-05-05
JPH05504473A (ja) 1993-07-15
DE69033220T2 (de) 2000-01-20
AU6956391A (en) 1991-05-31
AU655918B2 (en) 1995-01-19
IE903930A1 (en) 1991-05-08
DE69033220D1 (de) 1999-08-26

Similar Documents

Publication Publication Date Title
JP3315405B2 (ja) レセプター誘発結合部位に対するモノクローナル抗体
FI109204B (fi) Immuunimäärityksiä ja monoklonaalisia vasta-aineita protrombiiniaktivaatiopeptideille ja niiden hajoamistuotteille
EP1557431B1 (fr) Analyses et réactifs permettant de quantifier le hbnp
WO1997032900A9 (fr) ANALYSES ET REACTIFS PERMETTANT DE QUANTIFIER LE hBNP
JPH06237786A (ja) 人フィブリンｉｉのｎｈ２ 末端フラグメントに対するモノクロナール抗体
US8940489B2 (en) Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody
AU641912B2 (en) Blood-coagulation factor XIIa beta monoclonal antibody and immunoassay
US5876947A (en) Monospecific antibody reactive with Fibrinogen and fibrinopeptide B
US6124107A (en) Assay for marker of human polymorphonuclear leukocyte elastase activity
KR960002740B1 (ko) 안티-트롬빈-결합물질 모노클로날 항체, 이를 생산하는 하이브리도마 및 모노클로날 항체를 이용한 트롬빈-결합물질의 정제법 및 측정법
Hursting et al. Monoclonal antibodies specific for prothrombin fragment 1.2 and their use in a quantitative enzyme-linked immunosorbent assay
EP0339302B1 (fr) Système de réactif pour essai immunologique du complexe de l'inhibiteur d'activeur plasminogène humain et de l'activeur plasminogène humain de tissu et trousse à cet effet
US5358850A (en) Sandwich immunoassay of β-n-acetylglucosaminidase and monoclonal antibody used therein
EP0913692A1 (fr) Essai immunologique pour procollagène-III-C-terminal propeptide
AU676907B2 (en) Immunoassay and test kit for thrombin-antithrombin III complex
US5827673A (en) Method of detecting myocardial infarction
JP4612922B2 (ja) 新規のモノクローナル抗体並びにｅ−Ｄモノマー、ｅ−Ｄダイマー、及びｅ−ＤＤ／Ｅ複合体の免疫学的分析方法
JP4318085B2 (ja) 抗体およびハイブリドーマ、並びにこれらを用いた免疫学的測定法
CA2070433A1 (fr) Methode et trousse de dosage immunologique d'un propeptide de l'osteocalcine et de la pro-osteocalcine
JPH0342572A (ja) ラミニン測定試薬
JP2008301833A (ja) 新規なモノクローナル抗体及びニックβ２グリコプロテインＩの免疫学的分析方法
JPH07258297A (ja) 抗ヒトｐｒｏｔｅｉｎ１モノクローナル抗体、およびハイブリドーマ

Legal Events

Date Code Title Description
MA Patent expired